Pyros Pharmaceuticals
About:
Pyros Pharmaceuticals is a generic drug company dedicated to developing and commercializing low-cost generics.
Website: https://pyrospharma.com/
Description:
Pyros Pharmaceuticals is a generic drug company dedicated to developing and commercializing low-cost generics. Its business strategy is focused on targeting high-value solid oral, sterile injectable, and alternative dosage form ANDAs that are difficult to develop and that bring sustainable profitability.
Total Funding Amount:
$880000
Estimated Revenue Range:
$1M to $10M
Headquarters Location:
New York, New York, United States
Founded Date:
2017-01-01
Contact Email:
bd(AT)pyrospharma.com.
Founders:
Edwin Urrutia, Michael Smith
Number of Employees:
11-50
Last Funding Date:
2022-03-21
IPO Status:
Private
Industries:
© 2025 bioDAO.ai